Lucae, S.Ising, M.Horstmann, S.Baune, B.Arolt, V.Muller-Myhsok, B.Holsboer, F.Domschke, K.2011-08-302011-08-302010European Neuropsychopharmacology, 2010; 20(1):65-680924-977X1873-7862http://hdl.handle.net/2440/65744Two serotonin 2A receptor (HTR2A) SNPs recently reported to be associated with antidepressant treatment response in STARD (rs7997012; rs1928040) were analyzed for association with treatment response in two independent Caucasian samples of patients with a Major Depressive Episode. In the combined sample (n=637) SNP rs7997012 was significantly associated with remission after five weeks providing first replicative support for the initial finding, with, however, an inverse allelic association as compared to the STARD sample.en© 2009 Elsevier B.V. and ECNP All rights reserved.HTR2APharmacogeneticsSNPTreatment responseMajor DepressionAssociation studyJournal article002011149310.1016/j.euroneuro.2009.08.0060002739418000062-s2.0-7154913044128280Baune, B. [0000-0001-6548-426X]